The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...
Tens of millions of pounds in investment is being provided by the group of firms which includes AstraZenecaa and Pfizer ...
Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...
Higher green tea consumption significantly reduces cerebral white matter lesions in older adults, offering potential ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
Research published Tuesday is the first to connect the dots between a common herpes virus, head injury, and Alzheimer's.